首页> 外文期刊>Nature Communications >Connecting genetic risk to disease end points through the human blood plasma proteome
【24h】

Connecting genetic risk to disease end points through the human blood plasma proteome

机译:通过人类血浆蛋白质组学将遗传风险与疾病终点联系起来

获取原文
       

摘要

Genome-wide association studies (GWAS) with intermediate phenotypes, like changes in metabolite and protein levels, provide functional evidence to map disease associations and translate them into clinical applications. However, although hundreds of genetic variants have been associated with complex disorders, the underlying molecular pathways often remain elusive. Associations with intermediate traits are key in establishing functional links between GWAS-identified risk-variants and disease end points. Here we describe a GWAS using a highly multiplexed aptamer-based affinity proteomics platform. We quantify 539 associations between protein levels and gene variants (pQTLs) in a German cohort and replicate over half of them in an Arab and Asian cohort. Fifty-five of the replicated pQTLs are located in trans . Our associations overlap with 57 genetic risk loci for 42 unique disease end points. We integrate this information into a genome-proteome network and provide an interactive web-tool for interrogations. Our results provide a basis for novel approaches to pharmaceutical and diagnostic applications.
机译:具有中间表型的全基因组关联研究(GWAS),例如代谢产物和蛋白质水平的变化,为绘制疾病关联并将其转化为临床应用提供了功能证据。然而,尽管数百种遗传变异与复杂的疾病有关,但潜在的分子途径通常仍然难以捉摸。具有中间性状的关联对于在GWAS识别的风险变量与疾病终点之间建立功能联系至关重要。在这里,我们描述了使用高度复用的基于适体的亲和蛋白质组学平台的GWAS。我们在德国队列中量化了539种蛋白质水平和基因变异之间的关联,并在阿拉伯和亚洲队列中复制了其中的一半以上。重复复制的pQTL中有55个位于trans中。我们的关联与42个独特疾病终点的57个遗传风险基因座重叠。我们将这些信息整合到基因组蛋白质组网络中,并提供一个用于询问的交互式网络工具。我们的结果为药物和诊断应用的新方法提供了基础。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号